Exagen, Inc. (XGN)
8.495
+0.24
(+2.97%)
USD |
NASDAQ |
Oct 13, 16:00
8.495
0.00 (0.00%)
After-Hours: 20:00
Exagen Cash from Investing (Quarterly) : -0.543M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.543M |
| March 31, 2026 | -0.228M |
| December 31, 2025 | -0.035M |
| September 30, 2025 | -0.275M |
| June 30, 2025 | -0.209M |
| March 31, 2025 | -0.107M |
| December 31, 2024 | -0.146M |
| September 30, 2024 | -0.147M |
| June 30, 2024 | -0.136M |
| March 31, 2024 | -0.086M |
| December 31, 2023 | -0.084M |
| September 30, 2023 | -0.002M |
| June 30, 2023 | -0.322M |
| March 31, 2023 | -0.396M |
| December 31, 2022 | -0.406M |
| September 30, 2022 | -0.879M |
| June 30, 2022 | -1.946M |
| March 31, 2022 | -1.087M |
| December 31, 2021 | -1.064M |
| September 30, 2021 | -0.475M |
| June 30, 2021 | -0.714M |
| March 31, 2021 | -0.167M |
| December 31, 2020 | -0.005M |
| September 30, 2020 | -0.213M |
| June 30, 2020 | -0.153M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.084M |
| December 31, 2019 | -0.026M |
| September 30, 2019 | -0.002M |
| June 30, 2019 | 0.288M |
| March 31, 2019 | -0.363M |
| December 31, 2018 | 0.929M |
| September 30, 2018 | 0.94M |
| June 30, 2018 | -0.016M |
| March 31, 2018 | -2.052M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -0.159M |
| September 30, 2015 | -0.244M |
| June 30, 2015 | -0.389M |
| March 31, 2015 | -0.008M |
| December 31, 2014 | -0.043M |
| September 30, 2014 | -0.181M |
| June 30, 2014 | -0.38M |
| March 31, 2014 | -0.045M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -3.20M |
| BioRestorative Therapies, Inc. | 0.9684M |
| CareDx, Inc. | 280.59M |
| Natera, Inc. | -63.43M |
| Sera Prognostics, Inc. | 6.394M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.988M |
| Cash from Financing (Quarterly) | -0.37M |
| Free Cash Flow | -7.588M |
| Free Cash Flow Per Share (Quarterly) | 0.1426 |
| Free Cash Flow to Equity (Quarterly) | 2.935M |
| Free Cash Flow to Firm (Quarterly) | 4.646M |
| Free Cash Flow Yield | -3.78% |